26
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Central congenital hypothyroidism caused by a novel mutation, C47W, in the cysteine knot region of TSHβ

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background:

          Isolated central congenital hypothyroidism (ICCH) is a rare form (1:50,000 newborn) of congenital hypothyroidism, which can present with growth and neuropsychological retardation. Unlike the more common primary CH (1:1,500–1:4,000), which presents on newborn screening with elevated serum thyroid stimulating hormone (TSH) and low thyroxine (T 4) and triiodothyronine (T 3), ICCH presents with low TSH and low thyroid hormone levels. ICCH therefore may be missed in most newborn screens that are based only on elevated TSH. Most cases of ICCH have been associated with mutations in the TSHβ gene.

          Patient:

          We present a consanguineous Sudanese family where the proband was diagnosed with “atypical” CH (serum TSH was low, not high).

          Intervention and Outcome:

          The propositus underwent whole exome sequencing and the C47W TSHβ mutation was identified. Sanger sequencing confirmed the proband to be homozygous for C47W and both parents were heterozygous for the same mutation. The mutation was predicted by several in silico methods to have a deleterious effect (SIFT 0.0, Damaging; Polyphen2_HDIV 0.973, probably damaging; MutationTaster 1, disease causing; and CADD 3.17, 16.62). C47W affects the first cysteine of the cysteine knot of the TSHβ subunit. The cysteine knot region of TSHβ is highly conserved across species and is critical for binding to the TSH receptor. Only two other mutations were previously reported along the cysteine knot and showed consistently low or undetectable serum TSH and low T 4 and T 3. Other TSHβ gene mutations causing ICCH have been reported in the “seatbelt” region, necessary for TSHβ dimerization with the alpha subunit.

          Conclusions:

          Identification of a mutation in TSHβ gene reinforces the importance of identifying of ICCH that can occur in the absence of elevated serum TSH and demonstrates the functional significance of the TSHβ cysteine knot.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: found
          • Article: not found

          Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules.

          The cystine knot three-dimensional structure is found in many extracellular molecules and is conserved among divergent species. The identification of proteins with a cystine knot structure is difficult by commonly used pairwise alignments because the sequence homology among these proteins is low. Taking advantage of complete genome sequences in diverse organisms, we used a complementary approach of pattern searches and pairwise alignments to screen the predicted protein sequences of five model species (human, fly, worm, slime mold, and yeast) and retrieved proteins with low sequence homology but containing a typical cystine knot signature. Sequence comparison between proteins known to have a cystine knot three-dimensional structure (transforming growth factor-beta, glycoprotein hormone, and platelet-derived growth factor subfamily members) identified new crucial amino acid residues (two hydrophilic amino acid residues flanking cysteine 5 of the cystine knot). In addition to the well known members of the cystine knot superfamily, novel subfamilies of proteins (mucins, norrie disease protein, von Willebrand factor, bone morphogenetic protein antagonists, and slit-like proteins) were identified as putative cystine knot-containing proteins. Phylogenetic analysis revealed the ancient evolution of these proteins and the relationship between hormones [e.g. transforming growth factor-beta (TGFbeta)] and extracellular matrix proteins (e.g. mucins). They are absent in the unicellular yeast genome but present in nematode, fly, and higher species, indicating that the cystine knot structure evolved in extracellular signaling molecules of multicellular organisms. All data retrieved by this study can be viewed at http://hormone.stanford.edu/.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Prediction of congenital hypothyroidism based on initial screening thyroid-stimulating-hormone

            Background In thyroid-stimulating-hormone (TSH)-based newborn congenital hypothyroidism (CH) screening programs, the optimal screening-TSH cutoff level is critical to ensuring that true cases of CH are not missed. Screening-TSH results can also be used to predict the likelihood of CH and guide appropriate clinical management. The purpose of this study is to evaluate the predictive value of various screening-TSH levels in predicting a diagnosis of CH in the Ontario Newborn Screening Program (ONSP). Methods The initial screening and follow-up data of 444,744 full term infants born in Ontario, Canada from April 1, 2006 to March 31, 2010 were analyzed. Confirmed CH cases were based on local endocrinologists’ report and initiation of thyroxine treatment. Results There were a total of 541 positive screening tests (~1/822 live births) of which 296 were true positives (~1:1,500 live births). Subjects were further subdivided based on screening-TSH and positive predictive values (PPV) were calculated. Twenty four percent in the 17–19.9 mIU/L range were true positives. In the 17–30 mIU/L range, 29 % were true positives with a significantly higher PPV for those sampled after (43 %) rather than before (25 %) 28 h of age (p < 0.02). Seventy three percent of neonates with an initial screening-TSH of ≥ 30 mIU/L and 97 % of those with ≥ 40 mIU/L were later confirmed to have CH. Conclusions Infants with modestly elevated screening positive TSH levels between 17 and 19.9 mIU/L have a significant risk (24 %) of having CH. The very high frequency of true positives in term newborns with initial TSH values ≥ 30mIU/L suggests that this group should be referred directly to a pediatric endocrinologist in an effort to expedite further assessment and treatment. Screen positives with a modestly elevated TSH values (17-19.9 mIU/L) need to be examined in more detail with extended follow-up data to determine if they have transient or permanent CH.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Comparative structure analyses of cystine knot-containing molecules with eight aminoacyl ring including glycoprotein hormones (GPH) alpha and beta subunits and GPH-related A2 (GPA2) and B5 (GPB5) molecules

              Background Cystine-knot (cys-knot) structure is found in a rather large number of secreted proteins and glycoproteins belonging to the TGFbeta and glycoprotein hormone (GPH) superfamilies, many of which are involved in endocrine control of reproduction. In these molecules, the cys-knot is formed by a disulfide (SS) bridge penetrating a ring formed by 8, 9 or 10 amino-acid residues among which four are cysteine residues forming two SS bridges. The glycoprotein hormones Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH), Thyroid-Stimulating Hormone (TSH) and Chorionic Gonadotropin (CG) are heterodimers consisting of non-covalently associated alpha and beta subunits that possess cys-knots with 8-amino-acyl (8aa) rings. In order to get better insight in the structural evolution of glycoprotein hormones, we examined the number and organization of SS bridges in the sequences of human 8-aa-ring cys-knot proteins having 7 (gremlins), 9 (cerberus, DAN), 10 (GPA2, GPB5, GPHα) and 12 (GPHβ) cysteine residues in their sequence. Discussion The comparison indicated that the common GPH-alpha subunit exhibits a SS bridge organization ressembling that of DAN and GPA2 but possesses a unique bridge linking an additional cysteine inside the ring to the most N-terminal cysteine residue. The specific GPHbeta subunits also exhibit a SS bridge organization close to that of DAN but it has two additional C-terminal cysteine residues which are involved in the formation of the "seat belt" fastened by a SS "buckle" that ensures the stability of the heterodimeric structure of GPHs. GPA2 and GPB5 exhibit no cys residue potentially involved in interchain SS bridge and GPB5 does not possess a sequence homologous to that of the seatbelt in GPH β-subunits. GPA2 and GPB5 are thus not expected to form a stable heterodimer at low concentration in circulation. Summary The 8-aa cys-knot proteins GPA2 and GPB5 are expected to form a heterodimer only at concentrations above 0.1 microM: this would be consistent with a short-term paracrine role but not with an endocrine role after dilution in circulation. Consequently, GPA2 and GPB5 could exert separate endocrine roles either during development and/or during adult life of both vertebrates and invertebrates.
                Bookmark

                Author and article information

                Journal
                101525157
                37172
                Horm Res Paediatr
                Horm Res Paediatr
                Hormone research in paediatrics
                1663-2818
                1663-2826
                16 January 2020
                08 January 2020
                2019
                23 June 2020
                : 92
                : 6
                : 390-394
                Affiliations
                [1 ]Department of Pediatrics and Child Health, Faculty of Medicine, University of Almughtaribeen, Khartoum, Sudan
                [2 ]Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida
                [3 ]Department of Pediatrics and Child Health, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
                [4 ]Department of Medicine, The University of Chicago, Chicago, Illinois.
                [5 ]Department of Pediatrics The University of Chicago, Chicago, Illinois.
                [6 ]Department of Committee on Genetics The University of Chicago, Chicago, Illinois.
                Author notes
                [*]

                RSE, RJB and YW contributed equally

                Author Contributions

                RSE and MAA identified the patient and wrote the first draft; RJB helped in the writing of the manuscript and did the clinical chemistries; MKC and YW performed the initial sequencing analyses and YW evaluated all sequencing; AMD and SR confirmed the measurements in Chicago, provided intellectual input for the analyses and revised the manuscript; REW was overall supervisor of the data collection, provided funding and wrote the manuscript which was approved by all authors.

                Corresponding author: Roy E. Weiss, MD, PhD, Department of Medicine, University of Miami Miller School of Medicine, 1120 NW 14 th St., Room 310F, Miami, FL 33136, rweiss@ 123456med.miami.edu , Fax: 305-243-2193, Tel: 305-243-1944
                Article
                PMC7308213 PMC7308213 7308213 nihpa1061729
                10.1159/000504981
                7308213
                31914441
                23ab5548-270d-4407-b639-109a2c9c0be2
                History
                Categories
                Article

                Central congenital hypothyroidism,TSH receptor,secondary hypothyroidism

                Comments

                Comment on this article